top of page

Marie Fortin, PhD, DABT, ERT Joins Advisory Board

Jun 28, 2023

Mimicry Solutions would like to welcome Marie Fortin, PhD, DABT, ERT to our Advisory Board! Dr. Fortin is an immensely accomplished toxicologist in the pharmaceutical industry, whose impact and accomplishments are globally recognized.

About Dr. Marie Fortin

Marie C. Fortin is Director of Toxicology at Jazz Pharmaceuticals. In this role, she designs nonclinical safety drug development programs to meet regulatory expectations and support adequate safety evaluation while optimizing consideration of the 3Rs. She develops in vitro and in vivo study protocols and oversees safety pharmacology and investigative and regulatory toxicology (non-GLP and GLP) studies. In addition, she contributes critical input on other aspects of drug development such as pharmacology and pharmacokinetics, evaluation of the risk-benefit ratio, and determination of first-in-human dose. As toxicology lead on multiple cross-functional teams, she authors the relevant sections or regulatory submissions and represents the toxicology function in regulatory interactions.

In addition, Dr. Fortin is Adjunct Professor in the Department of Pharmacology and Toxicology at the Ernest Mario School of Pharmacy at Rutgers University where she mentors graduate students, teaches in the Joint Program in Toxicology, and co-directs the graduate risk assessment course. In her previous industry and consulting roles, she authored or oversaw the development of multiple human health risk assessments for pesticides, metals, pharmaceuticals, cosmetic ingredients, and chemicals for all routes of exposure (oral, inhalation, dermal, parenteral) and managed an in vitro safety testing laboratory focused on organotypic models.

Dr. Fortin is a Board-certified and European-registered toxicologist who is particularly interested in the integration of new approaches to support the safety evaluation of pharmaceuticals and their translational application to the risk assessment of chemicals. She has received both her M.Sc. in Neurosciences (2004) and Ph.D. in Public Health - Toxicology (2009) from the Université de Montréal and completed a Postdoctoral Fellowship at the University of Medicine and Dentistry of New Jersey (now part of Rutgers University) (2011).

About Mimicry Solutions

Mimicry Solutions is disrupting the pharmaceutical industry with ARTEMIS™, a proprietary toxicology platform that is the first ever alternative to animal testing for drug safety assessments at the industry level. ARTEMIS™ will generate novel toxicological readouts that outperform animals, providing better safety assessments of new drugs, faster drug development timelines, and a reduced ethical burden in animal research. Learn more at

bottom of page